BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen XX, Xu YY, Wu R, Chen Z, Fang K, Han YX, Yu Y, Huang LL, Peng L, Ge JF. Resveratrol Reduces Glucolipid Metabolic Dysfunction and Learning and Memory Impairment in a NAFLD Rat Model: Involvement in Regulating the Imbalance of Nesfatin-1 Abundance and Copine 6 Expression. Front Endocrinol (Lausanne) 2019;10:434. [PMID: 31338065 DOI: 10.3389/fendo.2019.00434] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Z, Zhang J, You L, Wang T, Wang K, Wang L, Kong X, Gao Y, Sun X. Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine. Front Endocrinol 2022;13:1000727. [DOI: 10.3389/fendo.2022.1000727] [Reference Citation Analysis]
2 Wei YD, Chen XX, Yang LJ, Gao XR, Xia QR, Qi CC, Ge JF. Resveratrol ameliorates learning and memory impairments induced by bilateral hippocampal injection of streptozotocin in mice. Neurochem Int 2022;159:105385. [PMID: 35843421 DOI: 10.1016/j.neuint.2022.105385] [Reference Citation Analysis]
3 Gao XR, Chen Z, Fang K, Xu JX, Ge JF. Protective effect of quercetin against the metabolic dysfunction of glucose and lipids and its associated learning and memory impairments in NAFLD rats. Lipids Health Dis 2021;20:164. [PMID: 34789244 DOI: 10.1186/s12944-021-01590-x] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
4 Xu D, Yu Y, Xu Y, Ge J. Plasma Nesfatin-1: Potential Predictor and Diagnostic Biomarker for Cognitive Dysfunction in T2DM Patient. Diabetes Metab Syndr Obes 2021;14:3555-66. [PMID: 34408457 DOI: 10.2147/DMSO.S323009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Qi CC, Chen XX, Gao XR, Xu JX, Liu S, Ge JF. Impaired Learning and Memory Ability Induced by a Bilaterally Hippocampal Injection of Streptozotocin in Mice: Involved With the Adaptive Changes of Synaptic Plasticity. Front Aging Neurosci 2021;13:633495. [PMID: 33732137 DOI: 10.3389/fnagi.2021.633495] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
6 Zhou H, Ma C, Wang C, Gong L, Zhang Y, Li Y. Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease. Eur J Pharmacol 2021;898:173976. [PMID: 33639194 DOI: 10.1016/j.ejphar.2021.173976] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
7 Abenavoli L, Larussa T, Corea A, Procopio AC, Boccuto L, Dallio M, Federico A, Luzza F. Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease. Nutrients 2021;13:494. [PMID: 33546130 DOI: 10.3390/nu13020494] [Cited by in Crossref: 3] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
8 Tarantino G, Balsano C. Gastrointestinal peptides and nonalcoholic fatty liver disease. Curr Opin Endocrinol Diabetes Obes 2020;27:11-5. [PMID: 31815784 DOI: 10.1097/MED.0000000000000514] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
9 Jakubczyk K, Skonieczna-Żydecka K, Kałduńska J, Stachowska E, Gutowska I, Janda K. Effects of Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease-A Meta-Analysis. Nutrients 2020;12:E2435. [PMID: 32823621 DOI: 10.3390/nu12082435] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
10 Colognesi M, Gabbia D, De Martin S. Depression and Cognitive Impairment-Extrahepatic Manifestations of NAFLD and NASH. Biomedicines 2020;8:E229. [PMID: 32708059 DOI: 10.3390/biomedicines8070229] [Cited by in Crossref: 11] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
11 Zhou M, Hu N, Liu M, Deng Y, He L, Guo C, Zhao X, Li Y. A Candidate Drug for Nonalcoholic Fatty Liver Disease: A Review of Pharmacological Activities of Polygoni Multiflori Radix. Biomed Res Int 2020;2020:5462063. [PMID: 32382557 DOI: 10.1155/2020/5462063] [Reference Citation Analysis]
12 Milton-laskibar I, Aguirre L, Gómez-zorita S, Rolo AP, Portillo MP. The influence of dietary conditions in the effects of resveratrol on hepatic steatosis. Food Funct 2020;11:9432-44. [DOI: 10.1039/d0fo01943g] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]